Advertisement

Topics

Congress Weighs Repeal of Tax Credit for Rare Disease Drugs

17:06 EST 8 Nov 2017 | The New York Times News

Long untouchable, the incentive for development of orphan drugs is now a Republican target as lawmakers consider a broad tax overhaul.

Original Article: Congress Weighs Repeal of Tax Credit for Rare Disease Drugs

NEXT ARTICLE

More From BioPortfolio on "Congress Weighs Repeal of Tax Credit for Rare Disease Drugs"

Advertisement
Quick Search
Advertisement
Advertisement